Aidan Products

Add to Favorites

Naturopathic Physicians (ND), Physicians & Surgeons

Be the first to review!

23 Years

in Business

(480) 756-8900Call Visit WebsiteVisit Website Map & DirectionsDirections2223 W Pecos Rd Ste 6Chandler, AZ 85224 Write a ReviewWrite Review

Is this your business?

Customize this page.

Claim This Business

Hours

Do you know the hours for this business?

Aidan Products

General Practitioners

Fibromyalgia
“PGM(C-Statin) seems to be responsible for a lot of positive changes in my patients’ cancer treatment. My patients also report that they feel better and experience a reduction of symptoms on PGM.” “I use MPGC(Imm-Kine) not only for my cancer patients, but also for immune stimulation – for conditions such as fibromyalgia, chronic fatigue, HIV, chronic infections, and general immune dysfunction – and my patients feel great on it.”

View All Services

Provided by

Places Near Chandler with Naturopathic Physicians (ND)

Gilbert (11 miles)
Ahwatukee (11 miles)
Tempe (14 miles)
Higley (15 miles)

More Types of Alternative Medicine & Health Practitioners in Chandler

Nutritionists Acupuncture Hypnotists Aromatherapy Dietitians Biofeedback Therapists Hypnotherapy

More Info

Extra Phones: Fax: (480) 756-8906
Services/Products: Auto Ship Products, Vein Caps, C Satin, Delivery Serivces
Payment method: discover, visa, paypal, amex, all major credit cards, mastercard
Neighborhood: Via de Cielo
AKA: Aidan Products Inc
Other Link: https://www.aidanproducts.com/our-location.html
Categories: Naturopathic Physicians (ND), Physicians & Surgeons

Gallery

Be the first to add a photo!

Reviews

Hi there!
Be the first to review!

Click to Rate

Details

Phone: (480) 756-8900

Address: 2223 W Pecos Rd Ste 6, Chandler, AZ 85224

Website: https://www.aidanproducts.com/our-location.html

People Also Viewed

View similar Naturopathic Physicians (ND)

Suggest an Edit

Aidan Products

General Practitioners

Fibromyalgia
“PGM(C-Statin) seems to be responsible for a lot of positive changes in my patients’ cancer treatment. My patients also report that they feel better and experience a reduction of symptoms on PGM.” “I use MPGC(Imm-Kine) not only for my cancer patients, but also for immune stimulation – for conditions such as fibromyalgia, chronic fatigue, HIV, chronic infections, and general immune dysfunction – and my patients feel great on it.”

Autism
Disclosed are methods, compositions of matter, and cells, useful for the treatment of autism, social integrative disorders, and various cognitive abnormalities. The invention discloses, inter alia, means of substantially ameliorating or reversing the progression of autism through the administration of autologous and/or allogeneic stem cells, alone or in combination with mobilization agents. The use of stem cells and cells naturally possessing or endowed with angiogenic and anti-inflammatory activity are disclosed for autism either alone or in combination with various therapeutic interventions.

Ultrasound
ABSTRACT: The aim of this study was to evaluate the development of edema, and superficial and deep vein thrombosis (DVT) prophylaxis with an oral profibrinolytic agent (Flite Tabs, 150 mg pinokinase, Aidan, Tempe, AZ, USA) in long-haul flights (7-8 hours), in high-risk subjects. A group of 300 subjects was included; 76 were excluded for several problems including concomitant treatments; 204 were randomized into 2 groups (active treatment or placebo) to evaluate the effects of prophylaxis with Flite Tabs. An exercise program was used in both groups. The femoral, popliteal, tibial, and superficial veins were scanned with ultrasound before and within 90 minutes after flights. Of the included subjects, 92 of 103 controls and 94 of 101 treated subjects completed the study. Dropouts were due to connection problems. Age, gender, and risk distribution were comparable in the groups. In the treatment group, no DVT was observed. In the control group, 5 subjects (5.4%) had a DVT and there were 2 superficial thromboses (7 events in 92 subjects; 7.6%). At inclusion, edema was comparable in the 2 groups. After flights there was an increase in score in controls (+12%) in comparison with a decrease (-15%) in the Flite Tabs group (the difference in variation was statistically significant). Intention-to-treat analysis for thrombotic events shows 18 failures in controls (11 lost to follow-up + 7 thrombotic events) of 92 subjects (19.6%) in comparison with 7 failures (of 94 subjects, equivalent to 7.4%) in the treatment group (p < 0.05). Events were asymptomatic. In conclusion, Flite Tabs were effective in reducing thrombotic events and in controlling edema in high-risk subjects in long flights.

View All Services

Provided by